NCT02045719

Phase II Clinical Trial of Uncaria Tomentosa (Cat´s Claw) in Patients With Advanced Solid Tumors

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 51 (estimated)
• Sponsor: Faculdade de Medicina do ABC · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Cat's claw (Uncaria tomentosa) is a native amazonic plant that exhibits anti-inflammatory and antitumor properties. Patients and methods: This prospective phase II study will assess the effects of a 100-mg dose of a dry extract of U. tomentosa three times per day on individuals with advanced solid tumors, with no further therapeutic options and with at least 2 months life expectancy. In addition, several biochemical and inflammatory parameters will be analyzed.

Conditions

• Solid Tumors

Interventions

Type	Name	Description
DRUG	uncaria tomentosa (cat´s claw)

Timeline

• Start date: 2013-12-01
• Primary completion: 2014-07-01
• Completion: 2014-09-01
• First posted: 2014-01-27
• Last updated: 2014-01-27

Locations

1 site across 1 country: Brazil